Get the Stockscreener App
0.7699
1.29%
-0.0101
Pre-market:
.72
-0.0499
-6.48%
Biofrontera Inc stock is traded at $0.7699, with a volume of 514.71K.
It is down -1.29% in the last 24 hours and down -6.62% over the past month.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
See More
Previous Close:
$0.78
Open:
$0.832
24h Volume:
514.71K
Relative Volume:
1.16
Market Cap:
$8.97M
Revenue:
$39.19M
Net Income/Loss:
$-16.59M
P/E Ratio:
-0.3528
EPS:
-2.182
Net Cash Flow:
$-9.39M
1W Performance:
-13.25%
1M Performance:
-6.62%
6M Performance:
-16.05%
1Y Performance:
-29.37%
1-Day Range:
$0.73
$0.848
1-Week Range:
$0.6505
$0.96
52-Week Range:
$0.536
$1.19
Biofrontera Inc Stock (BFRI) Company Profile
Name
Biofrontera Inc
Sector
Phone
781-245-1325
Address
120 PRESIDENTIAL WAY,, WOBURN
Compare BFRI vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BFRI
Biofrontera Inc
|
0.7699 | 9.09M | 39.19M | -16.59M | -9.39M | -2.182 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 57.18B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.67 | 56.47B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.16B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.31 | 40.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
475.85 | 20.37B | 3.13B | 1.27B | 1.12B | 26.39 |
Biofrontera Inc Stock (BFRI) Latest News
Biofrontera announces FDA filing acceptance of supplemental new drug application for Ameluz® PDT in superficial Basal Cell Carcinoma - marketscreener.com
Biofrontera's light-based option for common skin cancer under FDA review - Stock Titan
Will Biofrontera Inc. stock go up in YEAR2025 Key Highlights & Real-Time Chart Breakout Alerts - mfd.ru
Biofrontera’s Ameluz shows strong results in actinic keratosis trial By Investing.com - Investing.com Australia
Biofrontera announces positive results in phase 3 study of Ameluz® PDT - marketscreener.com
Biofrontera Reports Positive Phase 3 Ameluz PDT Results - TipRanks
Biofrontera’s Ameluz shows strong results in actinic keratosis trial - Investing.com
Light therapy gel clears more actinic keratoses on limbs, neck - Stock Titan
Biofrontera (NASDAQ:BFRI) Trading Down 5.6% – Here’s What Happened - Defense World
Biofrontera Inc. (BFRI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Finviz
Is Biofrontera Inc. (BFRI) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Trading Action: What are the future prospects of Biofrontera IncEarnings Beat & Verified Short-Term Trading Plans - baoquankhu1.vn
Earnings Miss: Will Biofrontera Inc stock go up in YEARJuly 2025 Rallies & Community Trade Idea Sharing Platform - baoquankhu1.vn
Aug Selloffs: Is Pitney Bowes Inc Preferred Security a turnaround story2025 Support & Resistance & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Published on: 2026-01-27 12:03:44 - baoquankhu1.vn
Aug Catalysts: Can Biofrontera Inc stock outperform in a bear marketJuly 2025 Closing Moves & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Big Picture: Can Biofrontera Inc Equity Warrant sustain its profitabilityEarnings Recap Summary & Real-Time Price Movement Reports - baoquankhu1.vn
There's No Escaping Biofrontera Inc.'s (NASDAQ:BFRI) Muted Revenues Despite A 42% Share Price Rise - Sahm
Portfolio Update: Is Root Inc part of any major index2025 Fundamental Recap & Reliable Price Breakout Signals - baoquankhu1.vn
Can Biofrontera Inc Equity Warrant sustain its profitabilityWall Street Watch & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Update Recap: Is Brighthouse Financial Inc attractive at current valuationWeekly Profit Report & Capital Efficient Trade Techniques - baoquankhu1.vn
Merger Talk: Does Biofrontera Inc Equity Warrant stock reflect fundamentals2025 Bull vs Bear & Long-Term Safe Investment Ideas - baoquankhu1.vn
Can Biofrontera Inc. Equity Warrant stock maintain growth trajectoryJuly 2025 Closing Moves & Technical Buy Zone Confirmations - bollywoodhelpline.com
Aug Setups: Is Biofrontera Inc forming a breakout patternQuarterly Investment Review & AI Driven Stock Reports - baoquankhu1.vn
Gains Recap: Is Biofrontera Incs ROE strong enough2025 Market Overview & Expert Curated Trade Setups - baoquankhu1.vn
Biofrontera reports preliminary Q4 revenue $17M-$17.5M - TipRanks
Biofrontera reports record quarterly revenue in Q4 2025 By Investing.com - Investing.com Nigeria
Published on: 2026-01-14 07:20:22 - Bộ Nội Vụ
Pharma News: Can Biofrontera Inc Equity Warrant stock rebound after recent weakness2025 Trade Ideas & Fast Entry Momentum Alerts - Bộ Nội Vụ
Biofrontera reports record quarterly revenue in Q4 2025 - Investing.com
Record $17M quarter for Biofrontera as Ameluz PDT sales climb higher - Stock Titan
How Biofrontera Inc. Equity Warrant stock benefits from tech adoptionQuarterly Growth Report & Fast Exit and Entry Strategy Plans - ulpravda.ru
Can Biofrontera Inc. Equity Warrant stock deliver strong Q4 earningsWeekly Profit Summary & Community Consensus Trade Signals - Улправда
What Wall Street predicts for Biofrontera Inc. stock priceQuarterly Market Summary & Low Drawdown Investment Ideas - ulpravda.ru
Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones - Sahm
Will Biofrontera Inc. stock outperform Nasdaq indexWeekly Gains Summary & Smart Swing Trading Alerts - Улправда
Can Biofrontera Inc. Equity Warrant stock outperform in 2025 bull marketPortfolio Performance Report & Fast Gain Stock Trading Tips - Улправда
Will Biofrontera Inc. Equity Warrant stock benefit from infrastructure spendingJuly 2025 Selloffs & Weekly Market Pulse Updates - Улправда
Is Biofrontera Inc. Equity Warrant stock cheap at current valuationTrade Volume Summary & Daily Oversold Bounce Ideas - Улправда
Is Biofrontera Inc. Equity Warrant stock a safe haven assetJuly 2025 Trends & Weekly Watchlist for Consistent Profits - Улправда
Biofrontera reaches database lock milestone for skin treatment studies By Investing.com - Investing.com Australia
Will Biofrontera Inc. (AI10) stock outperform value peersMarket Trend Report & AI Enhanced Trade Execution Alerts - Улправда
Why Biofrontera Inc. (AI10) stock remains stableTake Profit & Accurate Entry/Exit Alerts - Улправда
Is Biofrontera Inc. Equity Warrant stock affected by interest rate hikesInflation Watch & High Conviction Buy Zone Alerts - Улправда
Biofrontera reaches database lock milestone for skin treatment studies - Investing.com
Biofrontera announces data base locks for two clinical studies - TipRanks
Biofrontera announces data base locks for two clinical studies supporting key data and regulatory milestones - marketscreener.com
Biofrontera completes transfer of Ameluz, RhodoLED FDA approval - MSN
Biofrontera Receives Nasdaq Notice on Bid Price Noncompliance - TipRanks
Biofrontera Received Notice of Noncompliance - TradingView — Track All Markets
Biofrontera Inc Stock (BFRI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.21%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):